Orthopedic

Getting under the skin of orthopedic implants

Materials like our PURASORB® polymer are ideal for use in resorbable orthopedic devices and implants. Not only do our solutions meet a wide range of design and processing criteria but they also provide excellent biocompatibility and biodegradability.

Resorbable orthopedic implants containing our biobased materials are today treating a wide range of injuries to the musculoskeletal system in areas like sports medicine, trauma and spinal surgery.

But our solutions don’t just benefit patients, they also benefit our customers: The PURASORB® family can be processed using conventional techniques like extrusion, compression molding and injection molding - and is compatible with various sterilization processes.

Resorbable orthopedic implants

The PURASORB portfolio is available across our Polylactide platform; our PLGA (lactide/glycolide copolymers) platform, and our Capro (lactide/caprolactone copolymers) platform.

Your name
Please tell us your name
Email
Please provide your email address

Please enter a valid email address
Telephone number
Company
Please tell us which company you work for
Country
Address
please enter your address
Postal code
Please enter your postal code
Intended application
Please give us some information on what the sample will be used for
Area of interest
Please select your market
Please type the numbers at position 3 and 2 to verify you are a real person
Please verify that you are a real person

Please check if the numbers you typed are correct
code

Your name
Please tell us your name
Company
Please tell us which company you work for
Email
Please provide your email address

Please enter a valid email address
Telephone number
Country
Enquiry
Please tell us what you are looking for or how we can help you.
How did you hear about us?
Please type the numbers at position 3 and 1 to verify you are a real person
Please verify that you are a real person

Please check if the numbers you typed are correct
code
Application
Please choose an application

Press releases

4/30/2021 7:00 AM Corbion Q1 2021 Interim Management Statement
Corbion reported organic net sales growth of 9.5%. Total net sales were € 251.5 million
4/23/2021 7:00 AM Corbion appoints Aurélie Dalbiez as Chief Human Resources Officer
Corbion announces the appointment of Aurélie Dalbiez as Chief Human Resources Officer and member of
4/22/2021 11:25 AM Corbion approach to lactic acid expansion advances sustainability agenda
Expanding production capacity to meet growing global demand for lactic acid while simultaneously achieving Corbion's

Show all press releases

Events

6/9/2021 Biopesticides Europe 2021 Conference - POSTPONED - new dates to be decided
Brussels | The Global and European biopesticides market has been growing steadily in recent years. With increasing
11/9/2021 CPhI
Milan, Italy | The world's largest pharmaceutical exhibition, CPhI Worldwide houses six zones representing each stage of the
11/10/2021 NYSCC
New York, USA | NYSCC Suppliers’ Day serves as one of the most important events on the industry calendar

Show all events

Getting under the skin of orthopedic implants

Product not available in your region

Contact us

Press releases

Events

Cookie use